StonvexLoading…
StonvexStonvexStonvexCore line items from SXC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $455.10M | $1.84B | $1.36B | $870.10M |
Operating Income | $4.40M | $-44.40M | $53.40M | $40.00M |
Net Income | $-4.40M | $-44.20M | $41.40M | $19.20M |
EPS (Diluted) | $-0.05 | $-0.52 | $0.48 | $0.22 |
Total Assets | $1.73B | $1.79B | $1.93B | $1.64B |
Total Liabilities | $1.12B | $1.16B | $1.21B | $934.40M |
Cash & Equivalents | $104.40M | $88.70M | $80.40M | $186.20M |
Free Cash Flow OCF − CapEx | $55.70M | $42.30M | $9.50M | $25.80M |
Shares Outstanding | 85.60M | 85.50M | 85.60M | 85.60M |